Stocksigma LogoStocksigma Logo

USFDA Concludes Inspection at Concord Biotech鈥檚 Valthera Facility With One Minor Observation

The USFDA concluded an inspection at Concord Biotech's Unit II formulation facility in Valthera, Gujarat, on 18th Sep'26

USFDA Concludes Inspection at Concord Biotech鈥檚 Valthera Facility With One Minor Observation

Concord Biotech Ltd 路 Others (Uncategorized) 路 18 Sept 2026, 3:52 pm

USFDA Concludes Inspection at Concord Biotech鈥檚 Valthera Facility With One Minor Observation The USFDA concluded an inspection at Concord Biotech's Unit II formulation facility in Valthera, Gujarat, on 18th Sep'26. The regulator issued one minor procedural observation that is not related to Good Manufacturing Practices (GMP). The company plans to submit a comprehensive response within the stipulated timeline and stated that the outcome will have no material impact on current business operations or existing product supplies from the facility.

Original exchange filing (PDF)

More announcements from Concord Biotech Ltd

All Concord Biotech Ltd announcements